Andrew A. Somogyi

1. Placebo‐controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression
   2016/03/30 by Chu Kiong Loo, C. K. Loo, Verònica Gálvez +18 · 27 citations
   Medicine · Psychology · Neuroscience · #Treatment of Major Depression #Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes #Neurotransmitter Receptor Influence on Behavior
2. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy
   2021/01/02 by Kristine R. Crews, Andrew A. Monte, Rachel Huddart +18 · 2 citations
   Medicine · Pharmacology, Toxicology and Pharmaceutics · #Diet and metabolism studies #Pharmaceutical studies and practices #Pharmacogenetics and Drug Metabolism
3. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA‐B Genotypes and Phenytoin Dosing: 2020 Update
   2020/08/12 by Jason H. Karnes, Allan E. Rettie, Andrew A. Somogyi +13 · 26 citations
   Medicine · Pharmacology, Toxicology and Pharmaceutics · #Drug-Induced Adverse Reactions #Pharmaceutical studies and practices #Pharmacovigilance and Adverse Drug Reactions